Soros Fund Management Global Blood Therapeutics Inc. ownership

Global Blood Therapeutics Inc.'s ticker is GBT and the CUSIP is 37890U108. A total of 245 filers reported holding Global Blood Therapeutics Inc. in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.

Soros Fund Management ownership history of Global Blood Therapeutics Inc.
ValueSharesWeighting
Q3 2022$17,025
+2407.4%
250,001
+1090.5%
0.29%
+2545.5%
Q4 2015$679
-23.3%
21,0000.0%0.01%
-15.4%
Q3 2015$88521,0000.01%